Back to Search
Start Over
mRNA based vaccines provide broad protection against different SARS-CoV-2 variants of concern
- Source :
- Emerging Microbes and Infections, Vol 11, Iss 1, Pp 1550-1553 (2022)
- Publication Year :
- 2022
- Publisher :
- Taylor & Francis Group, 2022.
-
Abstract
- In order to overcome the pandemic of COVID-19, messenger RNA (mRNA)-based vaccine has been extensively researched as a rapid and versatile strategy. Herein, we described the immunogenicity of mRNA-based vaccines for Beta and the most recent Omicron variants. The homologous mRNA-Beta and mRNA-Omicron and heterologous Ad5-nCoV plus mRNA vaccine exhibited high-level cross-reactive neutralization for Beta, original, Delta, and Omicron variants. It indicated that the COVID-19 mRNA vaccines have great potential in the clinical use against different SARS-CoV-2 variants.
Details
- Language :
- English
- ISSN :
- 22221751
- Volume :
- 11
- Issue :
- 1
- Database :
- Directory of Open Access Journals
- Journal :
- Emerging Microbes and Infections
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.45010f5b7974a4ea6d38515af71876f
- Document Type :
- article
- Full Text :
- https://doi.org/10.1080/22221751.2022.2081616